Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Decreases By 39.7%

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 531,900 shares, a drop of 39.7% from the January 15th total of 881,600 shares. Based on an average trading volume of 458,400 shares, the days-to-cover ratio is presently 1.2 days. Currently, 2.9% of the company’s shares are short sold.

Cosmos Health Price Performance

Shares of NASDAQ COSM opened at $0.62 on Friday. Cosmos Health has a 1-year low of $0.47 and a 1-year high of $1.58. The business has a 50-day moving average of $0.71 and a 200-day moving average of $0.84. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. The company has a market capitalization of $14.40 million, a price-to-earnings ratio of -0.25 and a beta of 5.56.

Insider Activity at Cosmos Health

In related news, CFO Georgios Terzis bought 85,778 shares of the firm’s stock in a transaction dated Friday, December 20th. The stock was bought at an average price of $0.58 per share, with a total value of $49,751.24. Following the completion of the transaction, the chief financial officer now directly owns 727,263 shares of the company’s stock, valued at approximately $421,812.54. This represents a 13.37 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Grigorios Siokas bought 257,334 shares of the firm’s stock in a transaction dated Friday, December 20th. The stock was bought at an average cost of $0.58 per share, with a total value of $149,253.72. Following the transaction, the chief executive officer now directly owns 3,774,314 shares of the company’s stock, valued at approximately $2,189,102.12. This trade represents a 7.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 688,750 shares of company stock worth $437,803. 15.61% of the stock is owned by insiders.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC lifted its stake in Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 193,432 shares of the company’s stock after buying an additional 43,704 shares during the period. Geode Capital Management LLC owned approximately 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.